Insulet Corp
$
116.06
0 (0%)
| Volume: | 881,350 | Avg Vol (1m): | 637,924 |
| Market Cap $: | 6.93 Bil | Enterprise Value $: | 7.21 Bil |
| P/E (TTM): | 504.62 | P/B: | 31.72 |
| Earnings Power Value | -9.66 |
| Net Current Asset Value | -3.8 |
| Tangible Book | 2.82 |
| Projected FCF | -6.59 |
| Median P/S Value | 67.25 |
| Graham Number | 3.82 |
| Peter Lynch Value | 0 |
| DCF (FCF Based) | 0 |
| DCF (Earnings Based) | 0 |
1Y (-%)
Manual of Stocks™ Web
Financial Strength : 5/10
GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| Current | vs industry | vs history | |
|---|---|---|---|
| Cash-to-Debt | 0.53 |
Cash-To-Debt ranked
higher than
61.21%
of
330
companies
in the
Medical Devices
industry.
Industry Max: 504099, Med: 2.32, Min: -16.34
PODD:
0.53
Ranked among companies with meaningful Cash-To-Debt only.
|
Cash-To-Debt range over the past 10 years
Min: 0.49, Med: 0.87, Max: 10000
Current: 0.53
|
| Equity-to-Asset | 0.24 |
Equity-to-Asset ranked
lower than
58.90%
of
309
companies
in the
Medical Devices
industry.
Industry Max: 0.99, Med: 0.63, Min: -24.4
PODD:
0.24
Ranked among companies with meaningful Equity-to-Asset only.
|
Equity-to-Asset range over the past 10 years
Min: -2.37, Med: 0.24, Max: 0.73
Current: 0.24
|
| Debt-to-Equity | 2.68 |
Debt-to-Equity ranked
lower than
64.55%
of
220
companies
in the
Medical Devices
industry.
Industry Max: 11.69, Med: 0.3, Min: 0.01
PODD:
2.68
Ranked among companies with meaningful Debt-to-Equity only.
|
Debt-to-Equity range over the past 10 years
Min: -23.94, Med: 2.2, Max: 316.51
Current: 2.68
|
| Debt-to-EBITDA | 9.83 |
Debt-to-EBITDA ranked
lower than
68.99%
of
158
companies
in the
Medical Devices
industry.
Industry Max: 3384.46, Med: 1.98, Min: 0.02
PODD:
9.83
Ranked among companies with meaningful Debt-to-EBITDA only.
|
Debt-to-EBITDA range over the past 10 years
Min: -8.05, Med: -2.64, Max: 237.18
Current: 9.83
|
| Interest Coverage | 1.26 |
Interest Coverage ranked
lower than
100.00%
of
212
companies
in the
Medical Devices
industry.
Industry Max: 10000, Med: 66.37, Min: 0.03
PODD:
1.26
Ranked among companies with meaningful Interest Coverage only.
|
Interest Coverage range over the past 10 years
Min: 0.95, Med: 0.95, Max: 1.26
Current: 1.26
|
| Piotroski F-Score | 6 |
0
1
2
3
4
5
6
7
8
9
| |
| Altman Z-Score | 6.15 |
DISTRESS
GREY
SAFE
| |
| Beneish M-Score | -2.50 |
Not Manipulator
Manipulator
| |
| WACC vs ROIC % |
ROIC 6.47%
WACC 5%
| ||
Profitability & Growth : 6/10
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
| Current | vs industry | vs history | |
|---|---|---|---|
| Operating Margin % | 5.78 |
Operating Margin ranked
higher than
60.58%
of
312
companies
in the
Medical Devices
industry.
Industry Max: 1148.46, Med: 1.96, Min: -47867.72
PODD:
5.78
Ranked among companies with meaningful Operating Margin only.
|
Operating Margin range over the past 10 years
Min: -89.89, Med: -14.41, Max: 5.78
Current: 5.78
|
| Net Margin % | 2.37 |
Net Margin ranked
higher than
57.69%
of
312
companies
in the
Medical Devices
industry.
Industry Max: 15538.12, Med: 1.4, Min: -45900
PODD:
2.37
Ranked among companies with meaningful Net Margin only.
|
Net Margin range over the past 10 years
Min: -109.56, Med: -23.4, Max: 2.37
Current: 2.37
|
| ROE % | 7.24 |
ROE ranked
lower than
50.33%
of
304
companies
in the
Medical Devices
industry.
Industry Max: 51.97, Med: 0.95, Min: -2921.66
PODD:
7.24
Ranked among companies with meaningful ROE only.
|
ROE range over the past 10 years
Min: -178.71, Med: -60.48, Max: 7.24
Current: 7.24
|
| ROA % | 1.60 |
ROA ranked
higher than
59.64%
of
332
companies
in the
Medical Devices
industry.
Industry Max: 1204.95, Med: -0.26, Min: -2520.55
PODD:
1.6
Ranked among companies with meaningful ROA only.
|
ROA range over the past 10 years
Min: -51.7, Med: -21.4, Max: 1.6
Current: 1.6
|
| ROC (Joel Greenblatt) % | 16.45 |
ROC (Joel Greenblatt) ranked
higher than
60.86%
of
327
companies
in the
Medical Devices
industry.
Industry Max: 8175, Med: 3.87, Min: -323166.67
PODD:
16.45
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
|
ROC (Joel Greenblatt) range over the past 10 years
Min: -217.31, Med: -82.41, Max: 16.45
Current: 16.45
|
| 3-Year Total Revenue Growth Rate | 28.80 |
3-Year Revenue Growth Rate ranked
higher than
92.52%
of
254
companies
in the
Medical Devices
industry.
Industry Max: 300.7, Med: 4.3, Min: -100
PODD:
25.8
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
|
3-Year Revenue Growth Rate range over the past 10 years
Min: 0, Med: 17.55, Max: 99.7
Current: 25.8
|
» PODD's 30-Y Financials
Financials (Next Earnings Date: 2019-08-02)
Guru Trades Click for details
Guru Trades in
SEC Filings
Gurus Latest Trades with NAS:PODD
» Interactive Chart
Peter Lynch Chart
Business Description
| Industry | Medical Devices » Medical Devices   NAICS : 339112   SIC : 3841 |
| Compare | OCSE:GN SZSE:300003 ASX:COH NYSE:PEN NAS:IART NYSE:GMED NAS:WMGI HKSE:01066 NAS:TNDM SZSE:300529 NAS:LIVN OCSE:AMBU B SZSE:002223 NAS:NUVA XSWX:TECN OCSE:OSSR TSE:6849 NAS:CNMD NYSE:ITGR TSE:3360 |
| Traded in other countries | GOV.Germany |
| Address | 100 Nagog Park, Acton, MA, USA, 01720 |
| Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and a wireless personal diabetes manager that controls the dosage and has an integrated blood glucose meter. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, more than 20,000 insulin-dependent diabetics in the United States have begun using it. | |
Ratios
| Current | vs industry | vs history | |
|---|---|---|---|
| PE Ratio (TTM) | 504.62 |
PE Ratio ranked
lower than
100.00%
of
180
companies
in the
Medical Devices
industry.
Industry Max: 8940, Med: 30.17, Min: 0.06
PODD:
504.62
Ranked among companies with meaningful PE Ratio only.
|
PE Ratio range over the past 10 years
Min: 357.09, Med: 484.39, Max: 1842.92
Current: 504.62
|
| Forward PE Ratio | 454.55 |
Forward P/E ranked
lower than
100.00%
of
52
companies
in the
Medical Devices
industry.
Industry Max: 454.55, Med: 25.06, Min: 3.33
PODD:
454.55
Ranked among companies with meaningful Forward P/E only.
| N/A |
| PE Ratio without NRI | 504.62 |
PE without NRI ranked
lower than
100.00%
of
179
companies
in the
Medical Devices
industry.
Industry Max: 8940, Med: 30.17, Min: 0.06
PODD:
504.62
Ranked among companies with meaningful PE without NRI only.
|
PE without NRI range over the past 10 years
Min: 357.09, Med: 484.39, Max: 1842.92
Current: 504.62
|
| PB Ratio | 31.72 |
PB Ratio ranked
lower than
61.94%
of
310
companies
in the
Medical Devices
industry.
Industry Max: 1180, Med: 3.06, Min: 0.07
PODD:
31.72
Ranked among companies with meaningful PB Ratio only.
|
PB Ratio range over the past 10 years
Min: 3.13, Med: 23.26, Max: 1235
Current: 31.72
|
| PS Ratio | 12.08 |
PS Ratio ranked
lower than
55.78%
of
294
companies
in the
Medical Devices
industry.
Industry Max: 1136.36, Med: 3.15, Min: 0.05
PODD:
12.08
Ranked among companies with meaningful PS Ratio only.
|
PS Ratio range over the past 10 years
Min: 1.98, Med: 6.99, Max: 20.04
Current: 12.08
|
| Price-to-Operating-Cash-Flow | 163.69 |
Price-to-Operating-Cash-Flow ranked
lower than
70.08%
of
127
companies
in the
Medical Devices
industry.
Industry Max: 1586.78, Med: 20.01, Min: 3.03
PODD:
163.69
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
|
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 72.2, Med: 178.28, Max: 3931
Current: 163.69
|
| EV-to-EBIT | 164.69 |
EV-to-EBIT ranked
lower than
100.00%
of
174
companies
in the
Medical Devices
industry.
Industry Max: 18456.56, Med: 24.76, Min: 0.63
PODD:
164.69
Ranked among companies with meaningful EV-to-EBIT only.
|
EV-to-EBIT range over the past 10 years
Min: -867.9, Med: -26.4, Max: 4733.3
Current: 164.69
|
| EV-to-EBITDA | 118.13 |
EV-to-EBITDA ranked
lower than
72.87%
of
188
companies
in the
Medical Devices
industry.
Industry Max: 18456.56, Med: 18.14, Min: 0.62
PODD:
118.13
Ranked among companies with meaningful EV-to-EBITDA only.
|
EV-to-EBITDA range over the past 10 years
Min: -404.9, Med: -23.75, Max: 1906
Current: 118.13
|
| EV-to-Revenue | 12.03 |
EV-to-Revenue ranked
lower than
54.37%
of
309
companies
in the
Medical Devices
industry.
Industry Max: 17078.6, Med: 3.73, Min: 0.05
PODD:
12.03
Ranked among companies with meaningful EV-to-Revenue only.
|
EV-to-Revenue range over the past 10 years
Min: 2.3, Med: 7.3, Max: 19.7
Current: 12.03
|
| Current Ratio | 4.36 |
Current Ratio ranked
higher than
90.74%
of
324
companies
in the
Medical Devices
industry.
Industry Max: 563.8, Med: 2.71, Min: 0.03
PODD:
4.36
Ranked among companies with meaningful Current Ratio only.
|
Current Ratio range over the past 10 years
Min: 0.67, Med: 4.79, Max: 393.45
Current: 4.36
|
| Quick Ratio | 3.71 |
Quick Ratio ranked
higher than
92.90%
of
324
companies
in the
Medical Devices
industry.
Industry Max: 563.8, Med: 2.03, Min: 0.02
PODD:
3.71
Ranked among companies with meaningful Quick Ratio only.
|
Quick Ratio range over the past 10 years
Min: 0.56, Med: 4.39, Max: 393.45
Current: 3.71
|
| Days Inventory | 99.33 |
Days Inventory ranked
higher than
88.78%
of
294
companies
in the
Medical Devices
industry.
Industry Max: 990.33, Med: 143.61, Min: 0.63
PODD:
99.33
Ranked among companies with meaningful Days Inventory only.
|
Days Inventory range over the past 10 years
Min: 32.97, Med: 52.65, Max: 103.06
Current: 99.33
|
| Days Sales Outstanding | 41.78 |
Days Sales Outstanding ranked
higher than
88.77%
of
276
companies
in the
Medical Devices
industry.
Industry Max: 907.73, Med: 69.21, Min: 0.13
PODD:
41.78
Ranked among companies with meaningful Days Sales Outstanding only.
|
Days Sales Outstanding range over the past 10 years
Min: 28.65, Med: 56.54, Max: 82.7
Current: 41.78
|
| Days Payable | 49.28 |
Days Payable ranked
higher than
68.20%
of
261
companies
in the
Medical Devices
industry.
Industry Max: 912.5, Med: 58.34, Min: 1
PODD:
49.28
Ranked among companies with meaningful Days Payable only.
|
Days Payable range over the past 10 years
Min: 28.7, Med: 46.32, Max: 52.46
Current: 49.28
|
Dividend & Buy Back
| Current | vs industry | vs history | |
|---|---|---|---|
| 3-Year Share Buyback Rate | -2.30 |
3-Year Share Buyback Rate ranked
higher than
79.92%
of
244
companies
in the
Medical Devices
industry.
Industry Max: 19.2, Med: -5.7, Min: -1393.3
PODD:
-2.3
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
|
3-Year Share Buyback Rate range over the past 10 years
Min: -354.5, Med: -7.55, Max: -0.9
Current: -2.3
|
Valuation & Return
| Current | vs industry | vs history | |
|---|---|---|---|
| Price-to-Tangible-Book | 41.16 |
Price-to-Tangible-Book ranked
lower than
58.33%
of
276
companies
in the
Medical Devices
industry.
Industry Max: 1180, Med: 4.5, Min: 0.07
PODD:
41.16
Ranked among companies with meaningful Price-to-Tangible-Book only.
|
Price-to-Tangible-Book range over the past 10 years
Min: 3.41, Med: 33.13, Max: 1123
Current: 41.16
|
| Price-to-Median-PS-Value | 1.73 |
Price-to-Median-PS-Value ranked
higher than
50.21%
of
237
companies
in the
Medical Devices
industry.
Industry Max: 20.13, Med: 1.02, Min: 0.02
PODD:
1.73
Ranked among companies with meaningful Price-to-Median-PS-Value only.
|
Price-to-Median-PS-Value range over the past 10 years
Min: 0.29, Med: 0.98, Max: 2.75
Current: 1.73
|
| Price-to-Graham-Number | 30.38 |
Price-to-Graham-Number ranked
lower than
100.00%
of
133
companies
in the
Medical Devices
industry.
Industry Max: 59.6, Med: 2.11, Min: 0.06
PODD:
30.38
Ranked among companies with meaningful Price-to-Graham-Number only.
|
Price-to-Graham-Number range over the past 10 years
Min: 24.89, Med: 37.08, Max: 49.27
Current: 30.38
|
| Earnings Yield (Joel Greenblatt) % | 0.59 |
Earnings Yield (Greenblatt) ranked
higher than
63.25%
of
332
companies
in the
Medical Devices
industry.
Industry Max: 158.73, Med: 0.74, Min: -2500
PODD:
0.59
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
|
Earnings Yield (Greenblatt) range over the past 10 years
Min: -81.6, Med: -2.3, Max: 0.8
Current: 0.59
|
More Statistics
| Revenue (TTM) (Mil) $ | 599.8 |
| EPS (TTM) $ | 0.23 |
| Beta | 0.51 |
| Volatility % | 47.79 |
| 52-Week Range $ | 70.8 - 122.19 |
| Shares Outstanding (Mil) | 59.68 |
Analyst Estimate
Piotroski F-Score Details
| Piotroski F-Score | 6 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA yoy | Y |
| CFROA > ROA | Y |
| Lower Leverage yoy | Y |
| Higher Current Ratio yoy | N |
| Less Shares Outstanding yoy | N |
| Higher Gross Margin yoy | Y |
| Higher Asset Turnover yoy | N |